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Tushar Satav,[a,b] Peter Korevaar,[c] Tom F. A. de Greef,[c] Jurriaan Huskens,*[a] and Pascal 
Jonkheijm*[a,b] 
Abstract: The modulation of the hierarchical nucleated self-
assembly of tri-β
3
-peptides has been studied. β
3
-Tyrosine provided a 
handle to control the assembly process through host-guest 
interactions with CB[7] and CB[8]. By varying the cavity size from 
CB[7] to CB[8] distinct phases of assembling tri-β
3
-peptides were 
arrested. Given the limited size of the CB[7] cavity, only one 
aromatic β
3
-tyrosine can be simultaneously hosted and hence CB[7] 
was primarily acting as an inhibitor of self-assembly. In strong 
contrast, the larger CB[8] can form a ternary complex with two 
aromatic amino acids and hence CB[8] was acting primarily as 
cross-linker of multiple fibers and hence promoting the formation of 
larger aggregates. General insights on modulating supramolecular 
assembly can lead to new ways to introduce functionality in 
supramolecular polymers. 
Our understanding of how synthetic peptides and other 
molecular systems self-assemble into helical structures has 
progressed over the last decades towards a process that mimics 
many aspects of nucleated assembly of proteins observed in 
nature.[1-6] As expected, the nucleated assembly of peptides 
requires distinct sequence motifs and their assembly can be 
modulated using conventional factors such as concentration, pH, 
time and temperature. More interestingly, the onset and 
regulation of peptide assembly can be activated by light or 
enzymatic switches.[7-8] In spite of these advances, the 
programmability of the hierarchical assembly of synthetic 
peptides and molecules into higher ordered fibrillar structures 
remains challenging in contrast to e.g. naturally occurring β-
sheets that hierarchically assemble into dimers, tetramers, 
protofibrils and finally large fibrillar aggregates.[9] In particular, 
recent research has demonstrated that the addition of chiral 
auxiliaries or seed molecules can lead to either the exclusive 
formation of metastable helical aggregates or allows control over 
fibrillar width and length as shown in mechanistic assembly 
studies on aromatic disc- and rod-like molecules.[10-14] Promising 
results have also been reported by Moore and co-workers to 
control the final outcome of the nucleated assembly of α-
peptides by the addition of polymer-peptide conjugates into 
discrete nanostructures.[15] Very recently, the addition of 
macrocycles CB[7] and CB[8] assisted the assembly of 
functional dimeric and tetrameric proteins, protein wires and cell 
clusters mediated by interactions of these macrocycles with 
aromatic amino acids in proteins.[16-21] Specific CB[7]-phenyl 
alanine interactions were used by Kim and co-workers to inhibit 
α-peptide fibril formation[22] and by Urbach and co-workers to 
inhibit a nonspecific protease.[18]  
α-Peptides composed of less than 15 amino acids 
generally do not adopt defined helical conformations, in absence 
of structural constraints. In strong contrast, a surprising aspect 
of β-peptides is that they adopt defined helical structures over 
very short sequences despite the presence of the additional 
methylene units, which would be expected to provide the 
backbone with an increased freedom of orientation.[23, 24] β-
Peptides, in particular oligomers of β3-amino acids, have evolved 
as an intensively investigated class of non-biological building 
blocks for new materials, catalysts and ligands for protein 
receptors.[23-31]  When properly designed β3-peptides assemble 
into monomeric 314-helical structures, a first step toward β-
peptide bundle formation. Studies of helical configurations in β-
peptides composed of as little as six residues suggested that the 
assembly proceeds through a nucleation step.[23, 32, 33] Distinct 
octameric bundles have been assembled when helical 12-mer 
β3-peptides were employed in which cationic and anionic side 
chains were alternated on one helical face, while β3-
homoleucine residues were introduced on a second helical 
face.[34, 35] While the assembly mechanism of shorter 3-mer β3-
peptides has not been reported so far, no attempts have been 
made to modulate β3-peptide assembly by addition of molecular 
components during the nucleation. The ability to modulate the 
outcome of hierarchically assembled structures could open up 
the ability to post-functionalize the structures and to employ 
assemblies of particular states as nanomaterials.  
Here we report the nucleated self-assembly of tri-β3-
peptides, composed of three β3-amino acids, into 
supramolecular fibrils. The modulating capability of the CB[n] on 
the nucleated self-assembly of tri-β3-peptides was also 
investigated. We found that by varying the cavity size from CB[7] 
to CB[8] distinct phases of assembling tri-β3-peptides can be 
arrested (Scheme 1). Given the limited size of the CB[7] cavity, 
only one aromatic amino acid can be simultaneously hosted and 
hence CB[7] is primarily acting as an inhibitor of self-assembly. 
In strong contrast, the larger CB[8] can form a ternary complex 
with two aromatic amino acids and hence CB[8] is acting 
primarily as cross-linker of multiple fibers and hence promoting 
the formation of larger aggregates. The binding constants 
between β3-tyrosine with CB[7] or CB[8] were determined by ITC 
to be K = 1.4 x 105 M-1 (1:1 ratio) and K = 5.4 x 108  M-2 (2:1 
ratio), respectively (Figure S13). 
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A tri-β3-peptide (AcYSI, Scheme 1) was synthesized 
following standard procedures (Figures S1 and S2). This short tri 
β3-peptide is known to exhibit six axially oriented hydrogen 
bonding interactions facilitating the axial self-assembly during 
fiber formation as reported previously by others.[28] In the peptide 
design, β3-isoleucine facilitates aggregation by hydrophobic 
interactions, while β3-serine enhances water solubility. The N-
terminus is acetylated (Ac) to prevent formation of charges.  
Scheme 1. Hierarchical assembly of AcYSI. 
Finally, the presence of β3-tyrosine in the tri-β3-peptide further 
stabilizes the self-assembled structures via π-π stacking leading 
to the formation of larger fibrillar structures.[28] Importantly, the 
β3-tyrosine units also provide a handle to control the assembly 
process through host-guest interactions with CB[7] and CB[8]. 
First, the morphological changes upon adding CB[n]s to 
the self-assembled structures of AcYSI were visualized using 
SEM, AFM and optical microscopy (Figure 1). All samples were 
heated to 90˚C and cooled down to 20˚C to facilitate the 
possible entry of CB[n]s within the fibrils during the re-assembly 
of the peptides before depositing them onto a surface. 
Inspection of small deposits of concentrated solutions of AcYSI 
(3.9 mM) on various surfaces showed twisted fibrillar assemblies 
of several micrometers in length as readily observed using an 
optical microscope (Figure S3) and in agreement with 
observations by others.[28] In contrast, when 34 µM of CB[7] was 
added to these AcYSI assemblies, small fibrils were detected 
using AFM (Figure 1B), whereas larger fibrillar assemblies were 
observed using SEM upon adding 34 µM of CB[8] (Figure 1A). 
Interestingly, fibrils in the presence of CB[8] were larger in width 
and showed a more extended layered structure in comparison to 
fibers consisting of AcYSI alone (Figure S4A).  
Upon diluting the solution of AcYSI (without CB[n]s) to 0.39 
mM no fibrils were observed, and only ill-defined structures were 
observed using AFM (Figure 1C), however, at an intermediate 
concentration of 1.5 mM, wormlike fibrils were observed across 
the sample (Figure 1D). At this intermediate concentration, 
neither the addition of CB[7] nor CB[8] resulted in differences in 
assemblies (Figure S4C and S4D). While isolated large fibrils 
were present at high concentration (3.9 mM), as imaged with 
SEM and optical microscopy, smaller fibrils were detected in the 
background using AFM (Figure 1E). Based on these 
measurements, we conclude that the hierarchical assembly of 
these short tri-β3-peptides follows three stages. At low 
concentration monomeric tri-β3-peptides exist that predominantly 
form small fibrils at intermediate concentrations, while larger 
fibrils are formed at high concentrations. DLS measurements 
verified the involvement of different length scales in the 
assembly of AcYSI (Figure S5). At a low concentration (0.99 
mM), no fibrils were detected, whereas at an intermediate 
concentration of AcYSI (2.1 mM) aggregates of 141 nm in size 
were detected. At a high concentration of AcYSI (3.9 mM) larger 
aggregates of 240 nm were found in addition. Similar 
observations were made in amyloid assembly studies where 
protofibrils of intermediate size fuse to form larger, mature 
fibrils.[36] 
 
Figure 1. (A) SEM image of AcYSI (3.9 mM) and CB[8] (34 µM); (B) AFM 
image of AcYSI (3.9 mM) and CB[7] (34 µM). AFM images of AcYSI alone: (B) 
0.39 mM, (C) 1.5 mM and (D) 3.9 mM. Scale bars: (A) 100 µm; inset, (B), (C) 
and (D) 200 nm. 
 
To gain further understanding into the mechanism of 
AcYSI assembly, CD spectroscopy was employed (Figure 2). No 
CD signal was observed in dimethyl sulfoxide and ethanol 
solutions up to a concentration of 3.9 mM of AcYSI, indicating 
that these solvents do not support the assembly of AcYSI. When 
0.30 mM AcYSI solutions were prepared in PBS buffer also no 
CD signal was observed, indicative of the absence of folded tri-
β3-peptides. In contrast, upon increasing the concentration of 
AcYSI, the CD signal rose, while simultaneously the wavelength 
at which the CD intensity has its maximum value (λmax) shifted 
bathochromically, signaling a gradual assembly of AcYSI into 
larger aggregates. A decrease in CD intensity and further red 
shift of λmax was observed upon further increasing the 
concentration of AcYSI. This is in agreement with previous 
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studies on α-peptides that have shown that desolvation of 
tyrosine residues due to inclusion of the aromatic group in the 
hydrophobic core of the fiber during assembly leads to a gradual 
red shift of λmax.
[37, 38] Taken together, the changes in CD as a 
function of AcYSI concentration are supporting the AFM and 
SEM observations and indicate a hierarchical assembly process 
of individual monomeric tri-β3-peptides (low concentration 
regime) into intermediate protofibrils (intermediate concentration 
regime) that interact to form mature fibrils (high concentration 
regime).  
When λmax is plotted against the AcYSI concentration 
(Figure 2B), dilute solutions of AcYSI show no shift of this value 
up to a critical concentration of 1.1 mM that marks a sudden 
change in λmax. This observation indicates the nucleation of the 
assembly process of helically folded peptides to form protofibrils. 
The concentration-dependent changes in this regime were 
analyzed using a nucleation-elongation model (Equation 3 in 
Supporting Information) assuming a nucleus size of two tri-β3-
peptides, which reveals that the aggregate growth is highly 
cooperative (Ke = 0.01 mM
-1). The growth of the protofibrils 
continues until 2.1 mM. At higher concentrations of AcYSI, up to 
3.9 mM, changes in λmax were monitored that deviate from the 
1D growth model indicating substantial cross-linking of 
protofibrils.[6]  
 
Figure 2. (A) CD spectra of AcYSI (PBS, 20°C) at low (below 1.1 mM, black), 
high (above 2.1 mM, green) or intermediate concentrations (1.1 – 2.1 mM). (B) 
λmax of CD spectra (PBS, 20°C, after heating) plotted vs AcYSI concentration 
(■), AcYSI with 34 µM CB[7] (▲) or CB[8] (●). Data is fitted with a nucleation-
elongation model (lines, see Supporting information for details). (C) CD 
spectra of AcYSI (3.9 mM), with 34 µM CB[7] or CB[8] after heating to 90°C 
and cooling down to 20°C (10°C/min). CD spectra of AcYSI (1.3 and 2.6 mM) 
are given for reference. (D) λmax of CD spectra plotted vs temperature for 1.1 
(■) and 3.9 mM (●) AcYSI; 3.9 mM AcYSI with 34 µM CB[7] (▼) or CB[8] (▲); 
1.1 mM AcYSI with 34 µM CB[7] (◄) or CB[8] (♦). 
 
Subsequently, the influence of temperature on the AcYSI 
assembly was investigated. To this end, AcYSI solutions were 
heated to 90˚C and cooled down at a rate of 10˚C/min (Figures 
S6 and S7). In the case of high concentrations (above 2.1 mM) 
of AcYSI, CD spectra showed no change, indicating that the 
secondary structure of AcYSI at these concentrations is 
insensitive to temperature. Yet, in the case of intermediate 
concentrations of AcYSI (1.1 - 2.1 mM), no CD signal was found 
at 90˚C, indicating that protofibrils were disassembled, while 
from 70˚C to 20˚C the CD intensity gradually restored without 
hysteresis indicating that the protofibrils were completely re-
assembled. Figure 2D shows for both concentration regimes a 
nearly temperature independent λmax. In the intermediate 
concentration regime (Figure 2D, black), where AcYSI is in the 
protofibrillar state up to 70˚C, λmax  is 201.5 nm, whereas in the 
high concentration regime (Figure 2D, red), where AcYSI is in 
mature fibril state, λmax  is 207 nm.  
Next, either 34 µM of CB[7] or CB[8] was added to AcYSI 
in the protofibrillar state (intermediate concentration regime, 1.1 
mM AcYSI) at 20˚C. No significant shift in λmax was observed 
when compared to spectra of AcYSI alone (Figure S8A and 
S9A). When CB[n]s were added to AcYSI in the disassembled 
state at 90˚C, after cooling down at 10°C/min, the melting curve 
closely resembled that of AcYSI alone (Figure 2D, magenta and 
light blue). These results indicate that the macrocycles are not 
changing the protofibrillar assembly of AcYSI, which is in 
agreement with AFM data showing the presence of protofibrils 
(Figure S4C and S4D) as were observed for AcYSI (Figure 1D).  
To investigate the influence of CB[7] and CB[8] on the 
mature fibril state of AcYSI, 34 µM of CB[7] or CB[8] was added 
to AcYSI in the high concentration regime (3.9 mM) at 20˚C. 
Much to our surprise addition of CB[n]s led to an immediate 
hypsochromic shift of λmax for both samples (Figure S8B and 
S9B) indicative of hindered maturation of fibrils by CB[7] and 
CB[8] as these CD spectra closely resemble that of AcYSI alone 
in the intermediate concentration regime where AcYSI is in the 
protofibrillar state. Interestingly, the spectra remained the same 
for at least 24h and the shift in λmax depends on the amount of 
macrocycles added. A CB[n]:β-Tyr ratio of 0.001 (4 µM CB[n]) 
appeared sufficient to modulate the assembly pathway (Figure 
S10).  
To examine whether kinetically trapped aggregates were 
formed, in the next experiment concentrated (3.9 mM) AcYSI 
solutions were heated to 90˚C and in the presence of 34 µM 
CB[7] or CB[8] (CB[n]:β3-Tyr ratio of 0.01) cooled down to 20˚C 
at 10˚C/min (Figure S8B and S9B). The same shift in λmax of the 
π-π* transition was still observed for CB[7] (Figure 2D, blue), 
while, in strong contrast, for CB[8] λmax only shifted to 204 nm 
(Figure 2D, green) closely resembling the CD spectrum of AcYSI 
in the high concentration regime (2.6 mM). These results can be 
interpreted as follows. The CD spectrum of AcYSI (3.9 mM) in 
the presence of CB[8] and after heating is comparable to that 
AcYSI (2.6 mM) in the absence of CB[8] (Figure 2C), which 
indicates fibrils were formed with less intimate contacts were 
formed compared to AcYSI alone at 3.9 mM. This is in 
agreement with SEM images that showed a more extended 
layered fibril formation in the presence of CB[8] (Figure S4). 
These observations suggest that mature fibrils can form in the 
presence of CB[8], but that these fibrils are locally frustrated due 
to intercalation of CB[8], similar as observed previously in the 
case of assembling cross-linked rod-like molecules.[39] When 
compared to the sample prior to heating, the CD spectrum of 
AcYSI and CB[8] resembles that of intermediate concentrations 
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of AcYSI alone, indicative of the protofibrillar state (Figure 2C). 
In contrast, in the case of CB[7] a much larger hypsochromic 
shift to λmax = 201 nm was observed, indicating that CB[7] 
successfully suppresses the formation of mature fibrils, as 
witnessed by the match of λmax with that of AcYSI alone at 
intermediate concentrations (Figure 2C). AFM inspection 
revealed in this case similar structures (Figure 1B) as observed 
for AcYSI in the intermediate concentration range. These results 
clearly show that CB[7] and CB[8] have distinct influences on the 
assembly of AcYSI in the high concentration regime. In contrast 
to CB[8], CB[7] can only bind a single tyrosine unit as was 
confirmed by ITC. As such it can inhibit the lateral assembly of 
protofibrils into mature fibrils thus arresting the assembly in the 
protofibrillar stage. Irrespective of temperature ramping CB[7] 
can stably arrest the photofibrillar state while CB[8] can cross-
link these into larger fibrils depending on the equilibrating 
conditions. 
To further investigate the modulation of the AcYSI 
assembly, CD spectra were measured of a series of solutions of 
AcYSI (0.59 to 3.9 mM) in the presence of CB[n] (CB[n]:AcYSI 
ratio remained constant, Figure S11). Figure 2B shows the 
change in λmax against AcYSI concentration revealing that the 
presence of CB[n]s yields distinct shifts of λmax with a strong 
difference between CB[7] and CB[8]. The assembly of AcYSI, in 
the presence of CB[8], nucleated at the same concentration as 
AcYSI alone, however the cooperativity is less (Ke = 0.7 mM
-1). 
Also, the CD intensity is lower and λmax is blue shifted indicating 
that complexation with CB[8] leads to less extended order of the 
fibrils, which is in agreement with SEM images in Figure S4. In 
the case of AcYSI in the presence of CB[7], nucleation-
elongation is suppressed efficiently, only above 2.5 mM some 
higher order assembly is taking place. Solutions of AcYSI (high 
concentration) and AcYSI with CB[8] also showed a markedly 
higher viscosities compared to solutions with CB[7] similar to 
intermediate solutions of AcYSI (Figure S12). This observation 
further corroborated that the macrocycles are interfering with the 
assembly of AcYSI, suggesting that, in the case of CB[8], a 
cross-linked network is formed that is not present in the case of 
CB[7]. This difference can be related to the possibility of CB[8] 
for binding two β3-tyrosines from opposite sides of the cavity 
thus serving as a cross-linker between two protofibrils and 
yielding more viscous samples when compared to CB[7], in 
which case the mono-Tyr binding inhibits the lateral interaction 
of peptide fibrils. These observations are in good agreement 
with findings from the morphological study where large fibrils 
were observed in the case of CB[8], while in the presence of 
CB[7] no large fibrils were detected. 
In conclusion, the results demonstrate that the self-
assembly process of short trimeric β3-peptides can be 
modulated by addition of CB[n]s. We achieved different phases 
of chiral assemblies by controlling the lateral interactions of 
peptide protofibrils. General insights on modulating 
supramolecular assembly[40] can lead to new ways to introduce 
functionality in supramolecular polymers. 
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Nucleation dependent assembly of a 
short trimer β3-peptide can be 
changed using cucurbit[n]urils. While 
CB[7] with a smaller cavity size can 
lead to the formation of protofibrils, 
CB[8] with a larger cavity size can 
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